Dr. Reddy’s facility in Andhra Pradesh gets 2 U.S. FDA observations

The company will address the observations within the stipulated timeline.

Related stories

business

HCLTech rolls out a bouquet of industry AI solutions

business

DoT refutes bias in Starlink authorisation, says all licensees’ approvals pending

business

Chrysler Building to get its crown restored after being sold

business

Bid to run new trains on West Coast Mainline refused